Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GamEvac-Lyo vaccine for Ebola Virus Disease
NCT03333538Phase 2Completed
- Start
- Nov 2017
- Primary completion
- Nov 2018
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GamEvac-Lyo in Ebola virus disease (EVD). Started Nov 2017; status: completed.
02
Drugs
GamEvac-Lyo
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT03333538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333538.